WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™, today announced that John Rossi, Ph.D., scientific co-founder of and scientific advisory board chair for Dicerna, as well as professor in the Division of Molecular Biology and dean, Graduate School of Biological Sciences at City of Hope's Beckman Research Institute, will speak at the American Association of Pharmaceutical Scientists (AAPS) 2008 Annual Meeting and Exposition in Atlanta, GA.
